Prime medicine unveils program for the treatment of alpha-1 antitrypsin deficiency (aatd)

-- prime editing has potential to be best-in-class approach for aatd -- -- previously undisclosed program now emerging from within liver platform; leverages proprietary, universal liver lnp --
PRME Ratings Summary
PRME Quant Ranking